Evommune, Inc. Share Price
NYSE: EVMN | Micro CapEvommune, Inc. Stock Performance
Evommune, Inc. Share Price Today
As of 30 October 2026, Evommune, Inc.'s share price is $6.83. The stock opened at $6.40, compared to its previous close of $6.29. During today's trading session, Evommune, Inc.'s share price traded between $6.39 and $7.18, with an average price of $6.79. Over the past 52 weeks, the stock has recorded a high of $33.08 and a low of $4.94. In terms of performance, Evommune, Inc.'s share price has declined by 71.19% over the last six months and is down 66.40% on a year-on-year basis.
Evommune, Inc. Share Price Chart
Evommune, Inc. Quarterly Profit & Loss
All figures in USD
Evommune, Inc. Annual Profit & Loss
All figures in USD
About Evommune, Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Evommune, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $8.18 | $6.82 | -17.03% |
Sep 2026 | $12.54 | $8.22 | -38.88% |
Aug 2026 | $11.17 | $13.45 | +19.66% |
Jul 2026 | $13.30 | $11.24 | -15.36% |
Jun 2026 | $22.98 | $13.28 | -42.78% |
May 2026 | $23.60 | $23.21 | -2.09% |
Apr 2026 | $24.57 | $23.70 | +3.07% |
Mar 2026 | $25.70 | $23.00 | -11.93% |
Feb 2026 | $18.66 | $26.11 | +44.84% |
Jan 2026 | $17.64 | $18.03 | +5.38% |
Dec 2025 | $22.64 | $17.11 | -15.82% |
Nov 2025 | $17.31 | $20.32 | N/A |